What is the Cost of Cibinqo?
The price of Cibinqo (abrocitinib) can vary depending on the dosage and the pharmacy. For example, a 30-day supply of Cibinqo 100 mg tablets can cost around $7,000 to $7,600. The 200 mg dosage for the same duration may range from $7,300 to $7,800 [1]. These figures represent the retail price and do not account for potential discounts or insurance coverage.
How Can I Get Help with Cibinqo Costs?
For eligible patients, Pfizer, the manufacturer of Cibinqo, offers programs to help reduce out-of-pocket expenses. The "Pfizer Brilliant Savings Program" can provide a savings card that may lower the cost to as little as $10 per prescription for commercially insured patients [1]. Specific eligibility requirements apply, and the program details can be found on the Cibinqo website or through patient assistance resources.
When Does Cibinqo's Patent Expire?
Information on specific patent expiration dates for Cibinqo is generally available through resources that track pharmaceutical patents. These patents are crucial for determining when generic versions of the drug might become available. DrugPatentWatch.com is a source that provides detailed patent information for various medications, including potential expiration timelines [2].
What are the Alternatives to Cibinqo?
Several other medications are available for treating atopic dermatitis, Cibinqo's primary indication. These include other JAK inhibitors, as well as biologic drugs and topical treatments. The choice of an alternative often depends on the severity of the condition, patient response, and tolerance to specific drug classes. Some commonly prescribed alternatives include dupilumab (Dupixent), tralokinumab-ldrm (Adbry), and upadacitinib (Rinvoq) [3].
What is Cibinqo Used For?
Cibinqo is a Janus kinase (JAK) inhibitor approved for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years of age and older whose disease is not adequately controlled by other systemic or topical therapies [1]. It works by inhibiting certain enzymes in the body that contribute to inflammation and itching associated with atopic dermatitis.
What are the Risks Associated with Cibinqo?
As with any medication, Cibinqo carries potential risks and side effects. Serious risks include major adverse cardiovascular events, thrombosis, malignancy, and death, particularly in certain patient populations. Common side effects reported by patients include upper respiratory tract infections, headache, acne, and elevated levels of liver enzymes [1]. It is important for patients to discuss all potential risks with their healthcare provider before starting treatment.
---
Sources:
[1] Cibinqo Official Website
[2] DrugPatentWatch.com
[3] Medical literature and clinical trial data on atopic dermatitis treatments